The risks versus the benefits of pharmacological intervention in social anxiety disorder in children

被引：0
作者：
Hofmann, Stefan G. [1 ]
Kasch, Chantal [1 ]
Pereira, Bruno [1 ]
Barbosa, Carolina [1 ]
Andreoli, Giovanbattista [1 ,2 ]
机构：
[1] Philipps Univ Marburg, Dept Psychol, Schulstr 12, D-35037 Marburg, Germany
[2] Univ Bologna, Dept Psychol, Bologna, Italy
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2025年
关键词：
Social anxiety disorder; children; pharmacological treatment; psychotherapy; anxiety disorders; cognitive behavioral therapy; COGNITIVE-BEHAVIORAL THERAPY; PEDIATRIC ANXIETY; PRENATAL EXPOSURE; CONTROLLED-TRIAL; ADOLESCENTS; CHILDHOOD; PHARMACOTHERAPY; SCHOOL; FLUOXETINE; COMORBIDITY;
D O I：
10.1080/14737175.2025.2461763
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IntroductionMany children are affected by social anxiety disorder (SAD). Pharmacotherapy, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), may be indicated, but a clear understanding of the risks and benefits associated with these pharmacological treatments is needed.Areas coveredThis expert review explores the risks and benefits of pharmacotherapy for treating SAD in children.Expert opinionPharmacotherapy may be considered as a treatment when symptoms are complex or severe or when effective psychotherapy, such as cognitive behavioral therapy (CBT), is not accessible. We recommend that clinicians collaborate closely with parents, pediatricians, and psychiatrists in the treatment planning process, while monitoring the effects of pharmacotherapy. Future research should prioritize the personalization of treatments.
引用
收藏
页码：299 / 310
页数：12
相关论文
共 97 条
  • [81] Tandt H, 2009, Tijdschr Psychiatr, V51, P387
  • [82] Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study
    Taylor, Jerome H.
    Lebowitz, Eli R.
    Jakubovski, Ewgeni
    Coughlin, Catherine G.
    Silverman, Wendy K.
    Bloch, Michael H.
    [J]. JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, 2018, 47 (02) : 266 - 281
  • [83] A Systematic Review of Pharmacologic Treatments for School Refusal Behavior
    Tobon, Amalia Londono
    Reed, Margot O.
    Taylor, Jerome H.
    Bloch, Michael H.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (06) : 368 - 378
  • [84] The Role of Cognitive Factors in Childhood Social Anxiety: Social Threat Thoughts and Social Skills Perception
    van Niekerk, Rianne E.
    Klein, Anke M.
    Allart-van Dam, Esther
    Hudson, Jennifer L.
    Rinck, Mike
    Hutschemaekers, Giel J. M.
    Becker, Eni S.
    [J]. COGNITIVE THERAPY AND RESEARCH, 2017, 41 (03) : 489 - 497
  • [85] A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder
    Wagner, KD
    Berard, R
    Stein, MB
    Wetherhold, E
    Carpenter, DJ
    Perera, P
    Gee, M
    Davy, K
    Machin, A
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2004, 61 (11) : 1153 - 1162
  • [86] Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
    Walkup, John T.
    Albano, Anne Marie
    Piacentini, John
    Birmaher, Boris
    Compton, Scott N.
    Sherrill, Joel T.
    Ginsburg, Golda S.
    Rynn, Moira A.
    McCracken, James
    Waslick, Bruce
    Iyengar, Satish
    March, John S.
    Kendall, Philip C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (26) : 2753 - 2766
  • [87] Fluvoxamine for the treatment of anxiety disorders in children and adolescents
    Walkup, JT
    Labellarte, MJ
    Riddle, MA
    Pine, DS
    Greenhill, L
    Klein, R
    Davies, M
    Sweeney, M
    Abikoff, H
    Hack, S
    Klee, B
    McCracken, J
    Bergman, L
    Piacentini, J
    March, J
    Compton, S
    Robinson, J
    O'Hara, T
    Baker, S
    Vitiello, B
    Ritz, LA
    Roper, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) : 1279 - 1285
  • [88] Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders
    Walter, Heather J.
    Bukstein, Oscar G.
    Abright, A. Reese
    Keable, Helene
    Ramtekkar, Ujjwal
    Ripperger-Suhler, Jane
    Rockhill, Carol
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10) : 1107 - 1124
  • [89] Using Substances to Cope With Social Anxiety: Associations With Use and Consequences in Daily Life
    Walukevich-Dienst, Katherine
    Calhoun, Brian H.
    Fairlie, Anne M.
    Cadigan, Jennifer M.
    Patrick, Megan E.
    Lee, Christine M.
    [J]. PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2023, 37 (04) : 581 - 591
  • [90] Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders A Systematic Review and Meta-analysis
    Wang, Zhen
    Whiteside, Stephen P. H.
    Sim, Leslie
    Farah, Wigdan
    Morrow, Allison S.
    Alsawas, Mouaz
    Barrionuevo, Patricia
    Tello, Mouaffaa
    Asi, Noor
    Beuschel, Bradley
    Daraz, Lubna
    Almasri, Jehad
    Zaiem, Feras
    Larrea-Mantilla, Laura
    Ponce, Oscar J.
    LeBlanc, Annie
    Prokop, Larry J.
    Murad, Mohammad Hassan
    [J]. JAMA PEDIATRICS, 2017, 171 (11) : 1049 - 1056
12345678910